JULIE JOHNSON: Open Payments
NPI 1568512465 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,512 in 208 payments from 19 companies in 2025. Trend: 2023 $4,644 · 2024 $5,675 · 2025 $7,512
Food & beverage: $6,188Consulting: $1,140Education: $184
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $1,693 |
| ABBVIE INC. | 31 | $862 |
| GENZYME CORPORATION | 18 | $819 |
| Amgen Inc. | 17 | $546 |
| LEO Pharma Inc. | 14 | $452 |
| Novartis Pharmaceuticals Corporation | 15 | $436 |
| Janssen Biotech, Inc. | 15 | $423 |
| Galderma Laboratories, L.P. | 17 | $416 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $383 |
| Regeneron Healthcare Solutions, Inc. | 12 | $375 |
Products named: Bimzelx, DUPIXENT, RINVOQ, OTEZLA, ADBRY, TREMFYA, NEMLUVIO, SKYRIZI.
Industry payments across VA — which companies pay providers there.
